NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Stem Cell Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Stem Cell Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Stem Cell Transplantation



Dual-energy myocardial SPECT monitors transplanted cell distribution in relation to infarction site



August 14th, 2006

Dual-energy myocardial SPECT monitors transplanted bone marrow mesenchymal stem cell distribution in relation to the site of myocardial infarction.

According to a study from France, "Cell therapy using bone marrow mesenchymal stem cells (BMSCs) shows promise in the treatment of myocardial infarction (MI) but accurate cell delivery within MI areas remains critical.

"In the present study, we tested the feasibility of in vivo pinhole SPECT imaging for monitoring the sites of intramyocardial implanted BMSCs in relation to targeted MI areas in rats."

"BMSCs were labeled with 111In-oxine and injected within the fibrotic areas...


Source: Stem Cell Week (2006-08-14)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login